The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Debris from intercepted Houthi missiles injure 4, damage 15 homes in Riyadh
India's 'cockroach' movement leaders detained in jail for 5 days
Saudi Aramco administrative building targeted, minor blaze reported
6 deaths confirmed in Florida from Hurricane Isaias, governor says
Saudi-led coalition to prevent Houthis from using Yemeni facilities for attacks
